IL22 and acute-on-chronic liver failure: Also involved in TB and liver disease, IL-22 inhibits intracellular growth of Mycobacterium tuberculosis in human monocyte-derived macrophages [45] and is associated with acetaminophen-related hepatotoxicity and resolution of acute-on-chronic liver failure (ACLF) in small animal models [46,47].